Literature DB >> 32435372

Synthesis, Antiproliferative Effect, and Topoisomerase II Inhibitory Activity of 3-Methyl-2-phenyl-1H-indoles.

Nace Zidar1, Daniela Secci1, Tihomir Tomašič1, Lucija Peterlin Mašič1, Danijel Kikelj1, Daniele Passarella2, Aida Nelly Garcia Argaez3, Mariafrancesca Hyeraci3, Lisa Dalla Via3.   

Abstract

A series of 3-methyl-2-phenyl-1H-indoles was prepared and investigated for antiproliferative activity on three human tumor cell lines, HeLa, A2780, and MSTO-211H, and some structure-activity relationships were drawn up. The GI50 values of the most potent compounds (32 and 33) were lower than 5 μM in all tested cell lines. For the most biologically relevant derivatives, the effect on human DNA topoisomerase II relaxation activity was investigated, which highlighted the good correlation between the antiproliferative effect and topoisomerase II inhibition. The most potent derivative, 32, was shown to induce the apoptosis pathway. The obtained results highlight 3-methyl-2-phenyl-1H-indole as a promising scaffold for further optimization of compounds with potent antiproliferative and antitopoisomerase II activities.
Copyright © 2020 American Chemical Society.

Entities:  

Year:  2020        PMID: 32435372      PMCID: PMC7236043          DOI: 10.1021/acsmedchemlett.9b00557

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  24 in total

Review 1.  DNA topoisomerases: structure, function, and mechanism.

Authors:  J J Champoux
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 2.  A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade.

Authors:  Xiaoxia Liang; Qiang Wu; Shangxian Luan; Zhongqiong Yin; Changliang He; Lizi Yin; Yuanfeng Zou; Zhixiang Yuan; Lixia Li; Xu Song; Min He; Cheng Lv; Wei Zhang
Journal:  Eur J Med Chem       Date:  2019-03-20       Impact factor: 6.514

Review 3.  Mechanisms and regulation of DNA replication initiation in eukaryotes.

Authors:  Matthew W Parker; Michael R Botchan; James M Berger
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-01-17       Impact factor: 8.250

Review 4.  Recent developments of DNA poisons--human DNA topoisomerase IIα inhibitors--as anticancer agents.

Authors:  Barbara Pogorelčnik; Andrej Perdih; Tom Solmajer
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 5.  Topoisomerases as anticancer targets.

Authors:  Justine L Delgado; Chao-Ming Hsieh; Nei-Li Chan; Hiroshi Hiasa
Journal:  Biochem J       Date:  2018-01-23       Impact factor: 3.857

6.  Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis.

Authors:  B Mittra; A Saha; A R Chowdhury; C Pal; S Mandal; S Mukhopadhyay; S Bandyopadhyay; H K Majumder
Journal:  Mol Med       Date:  2000-06       Impact factor: 6.354

7.  Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors.

Authors:  Lars H Jensen; Annemette V Thougaard; Morten Grauslund; Birgitte Søkilde; Elisabeth V Carstensen; Henrik K Dvinge; Dominic A Scudiero; Peter B Jensen; Robert H Shoemaker; Maxwell Sehested
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

Review 8.  Drugging topoisomerases: lessons and challenges.

Authors:  Yves Pommier
Journal:  ACS Chem Biol       Date:  2013-01-04       Impact factor: 5.100

Review 9.  Discovery of small molecule cancer drugs: successes, challenges and opportunities.

Authors:  Swen Hoelder; Paul A Clarke; Paul Workman
Journal:  Mol Oncol       Date:  2012-03-03       Impact factor: 6.603

Review 10.  Recent developments in topoisomerase-targeted cancer chemotherapy.

Authors:  KirkE Hevener; Tatsiana A Verstak; Katie E Lutat; Daniel L Riggsbee; Jeremiah W Mooney
Journal:  Acta Pharm Sin B       Date:  2018-07-25       Impact factor: 11.413

View more
  2 in total

Review 1.  Target-based anticancer indole derivatives and insight into structure‒activity relationship: A mechanistic review update (2018-2021).

Authors:  Ashima Dhiman; Rupam Sharma; Rajesh K Singh
Journal:  Acta Pharm Sin B       Date:  2022-04-01       Impact factor: 14.903

2.  Biological Properties of New Chiral 2-Methyl-5,6,7,8-tetrahydroquinolin-8-amine-based Compounds.

Authors:  Giorgio Facchetti; Michael S Christodoulou; Lina Barragán Mendoza; Federico Cusinato; Lisa Dalla Via; Isabella Rimoldi
Journal:  Molecules       Date:  2020-11-27       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.